SCHEMBL23597989

SCHEMBL23597989

c1ccc(N(c2ccc3c(c2)C(c2ccccc2)(c2ccccc2)c2ccccc2-3)c2ccc3cc4c(cc3c2)C(c2ccccc2)(c2ccccc2)c2ccccc2-4)cc1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.40
▸ MAPT P10636 2/20 0.40
▸ MEN1 O00255 2/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ LMNA P02545 1/20 0.40
▸ OPRK1 P41145 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ PDK2 Q15119 3/20 0.38
▸ ALDH1A1 P00352 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ CYP2D6 P10635 1/20 0.33
▸ CYP2C9 P11712 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33
▸ TDP1 Q9NUW8 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ ESR1 P03372 1/20 0.32
▸ ESR2 Q92731 1/20 0.32
▸ POLB P06746 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23597916 0.99 KDM4E (0.39) KDM4EMAPTMEN1KMT2ALMNA
SCHEMBL23597988 0.99 KDM4E (0.39) KDM4EMAPTMEN1KMT2ALMNA
SCHEMBL23597894 0.97 KDM4E (0.41) KDM4EMAPTMEN1KMT2ALMNA
SCHEMBL23598093 0.97 KDM4E (0.41) KDM4EMAPTMEN1KMT2ALMNA
SCHEMBL24236425 0.96 KDM4E (0.36) KDM4EMAPTMEN1KMT2ALMNA
SCHEMBL19797207 0.93 KDM4E (0.41) KDM4EMAPTMEN1KMT2ALMNA
SCHEMBL19822141 0.93 KDM4E (0.41) KDM4EMAPTMEN1KMT2ALMNA
SCHEMBL13342076 0.93 KDM4E (0.34) KDM4EMAPTMEN1KMT2ALMNA
SCHEMBL23597912 0.93 PDK2 (0.40) KDM4EMAPTMEN1KMT2ALMNA
SCHEMBL21446672 0.93 PDK2 (0.40) KDM4EMAPTMEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210198167-A1 ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME DUPONT SPECIALTY MATERIALS KOREA LTD. (KR) 2021-07-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210198167-A1 ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME OR10J3, ELAVL1, ELAVL3 KDM4E 1047/4885MAPT 1558/4885MEN1 2891/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback